Patents by Inventor Vincent Moules

Vincent Moules has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral compositions for the treatment of infections linked to coronaviruses
    Patent number: 11510896
    Abstract: The present invention relates to a pharmaceutical or veterinary composition for its use in preventing and/or treating a MERS-CoV (Middle-East Respiratory Syndrome) coronavirus infection, characterised in that it comprises, in a suitable pharmaceutical vehicle, at least one compound chosen from apigenin and berberine.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: November 29, 2022
    Assignees: UNIVERSITE CLAUDE BERNARD LYON 1, INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Manuel Rosa-Calatrava, Olivier Terrier, Anaïs Proust, Vincent Moules
  • ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF INFECTIONS LINKED TO CORONAVIRUSES
    Publication number: 20190307722
    Abstract: The present invention relates to a pharmaceutical or veterinary composition for its use in preventing and/or treating a MERS-CoV (Middle-East Respiratory Syndrome) coronavirus infection, characterised in that it comprises, in a suitable pharmaceutical vehicle, at least one compound chosen from apigenin and berberine.
    Type: Application
    Filed: October 20, 2017
    Publication date: October 10, 2019
    Inventors: Manuel ROSA-CALATRAVA, Olivier TERRIER, Anaïs PROUST, Vincent MOULES
  • Modified viral strains and method for improving the production of vaccine seeds of influenza virus
    Patent number: 8956626
    Abstract: Modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus including a modified PB1 gene and methods for improving the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: February 17, 2015
    Assignees: Universite Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Vincent Moules, Manuel Rosa-Calatrava, Olivier Ferraris, Matthieu Yver
  • Modified Viral Strains and Method for Improving the Production of Vaccine Seeds of Influenza Virus
    Publication number: 20130115242
    Abstract: Modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus including a modified PB1 gene and methods for improving the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins.
    Type: Application
    Filed: July 8, 2011
    Publication date: May 9, 2013
    Applicants: UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), HOSPICES CIVILS DE LYON
    Inventors: Vincent Moules, Manuel Rosa-Calatrava, Olivier Ferraris, Matthieu Yver